KDM3A, a Novel Blood-Based Biomarker in Colorectal Carcinogenesis
Colorectal cancer (CRC) is one of the leading causes of cancer-linked deaths globally. The determination of biomarkers is important in the prognosis and treatment of CRC. Previous studies emphasized the relationship between hypoxia and CRC in humans, and there is strong evidence that this process is...
Main Authors: | Polat D., Onur E., Yılmaz N., Sökücü M., Gerçeker O.F. |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-12-01
|
Series: | Balkan Journal of Medical Genetics |
Subjects: | |
Online Access: | https://doi.org/10.2478/bjmg-2022-0021 |
Similar Items
-
The diagnostic performance of lysine(K)-specific demethylase 6B (KDM6B) in non-small cell lung cancer
by: Ting Ge, et al.
Published: (2019-12-01) -
Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target
by: Jung Yoo, et al.
Published: (2020-04-01) -
The Role of KDM2B and EZH2 in Regulating the Stemness in Colorectal Cancer Through the PI3K/AKT Pathway
by: Jaceline Gisliane Pires Sanches, et al.
Published: (2021-03-01) -
Depletion of Demethylase KDM6 Enhances Early Neuroectoderm Commitment of Human PSCs
by: Yajing Meng, et al.
Published: (2021-09-01) -
Cloning and Expression Analysis of Two Kdm Lysine Demethylases in the Testes of Mature Yaks and Their Sterile Hybrids
by: Zhenhua Shen, et al.
Published: (2020-03-01)